To include your compound in the COVID-19 Resource Center, submit it here.

PCI-32765: Interim Phase Ib/II data

Interim data from 39 evaluable patients in the ongoing, open-label, U.S.

Read the full 114 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE